Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-gradenon-Hodgkin's lymphoma

Buckstein, R Imrie, K Spaner, D Potichnyj, A Robinson, JB Nanji, S Pennel, N Reis, M Pinkerton, P Dube, I Hewitt, K Berinstein, NL

R. Buckstein et al., Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-gradenon-Hodgkin's lymphoma, SEMIN ONCOL, 26(5), 1999, pp. 115-122

21

Oncology,"Onconogenesis & Cancer Research

SEMINARS IN ONCOLOGY

00937754 → ACNP

26

5

1999

14

115 - 122

ISI

0093-7754(199910)26:5<115:SCFAEI>2.0.ZU;2-S